Pulverize Yam (D. Cayennensis) supplementation in the treatment of Gestational Diabetes Mellitus

Therapeutic perspective of Gestational Diabetes Mellitus with Yam Pulverize supplementation (D. Cayennensis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

REBEC

Registry ID

RBR-26ymzkc

Enrollment

Unknown

Registered

2024-04-08

Start date

2024-05-01

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes

Interventions

The present work is a phase II Experimental Clinical Study, randomized, double blind and placebo controlled. The research will be carried out at the Lauro Wanderley University Hospital located at the

C18.452.394.952

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Voluntary pregnant women with Gestational Diabetes Mellitus treated at the Lauro Wanderley University Hospital; over age

Exclusion criteria

Exclusion criteria: Pregnant women who are allergic to yams will be excluded; patients with kidney diseases; patients with liver or neurological diseases; pregnant women using multiple medications; minors

Design outcomes

Primary

Measure	Time frame
It is expected, better values in maternal and fetal nutritional parameters (maternal weight gain, baby birth weight, APGAR), clinical	—

Secondary

Measure	Time frame
In addition to the beneficial effects on the body, it is expected that a standard dosage of supplementation with yam flour capsules will be established	—

Countries

Brazil

Contacts

Public ContactTássia de Melo

Universidade Federal da Paraíba

tassia.s@hotmail.com.br55(83)3216-7791

Outcome results

None listed

Source: REBEC (via WHO ICTRP)